187 related articles for article (PubMed ID: 9316177)
1. Decision-making about genetic testing among women at familial risk for breast cancer.
Jacobsen PB; Valdimarsdottier HB; Brown KL; Offit K
Psychosom Med; 1997; 59(5):459-66. PubMed ID: 9316177
[TBL] [Abstract][Full Text] [Related]
2. Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.
Bluman LG; Rimer BK; Regan Sterba K; Lancaster J; Clark S; Borstelmann N; Iglehart JD; Winer EP
Psychooncology; 2003; 12(5):410-27. PubMed ID: 12833555
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
[TBL] [Abstract][Full Text] [Related]
4. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
5. Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.
Katapodi MC; Northouse LL; Milliron KJ; Liu G; Merajver SD
Psychooncology; 2013 Jun; 22(6):1336-43. PubMed ID: 22826208
[TBL] [Abstract][Full Text] [Related]
6. Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.
Phillips KA; Warner E; Meschino WS; Hunter J; Abdolell M; Glendon G; Andrulis IL; Goodwin PJ
Clin Genet; 2000 May; 57(5):376-83. PubMed ID: 10852372
[TBL] [Abstract][Full Text] [Related]
7. Attitudes about genetic testing for breast-ovarian cancer susceptibility.
Lerman C; Daly M; Masny A; Balshem A
J Clin Oncol; 1994 Apr; 12(4):843-50. PubMed ID: 8151327
[TBL] [Abstract][Full Text] [Related]
8. Spiritual faith and genetic testing decisions among high-risk breast cancer probands.
Schwartz MD; Hughes C; Roth J; Main D; Peshkin BN; Isaacs C; Kavanagh C; Lerman C
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):381-5. PubMed ID: 10794482
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
10. Genetic testing for susceptibility to breast cancer: findings from women's focus groups.
Tessaro I; Borstelmann N; Regan K; Rimer BK; Winer E
J Womens Health; 1997 Jun; 6(3):317-27. PubMed ID: 9201666
[TBL] [Abstract][Full Text] [Related]
11. Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.
Cappelli M; Surh L; Humphreys L; Verma S; Logan D; Hunter A; Allanson J
Clin Genet; 1999 Jun; 55(6):419-30. PubMed ID: 10450858
[TBL] [Abstract][Full Text] [Related]
12. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
[TBL] [Abstract][Full Text] [Related]
13. Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility.
Benkendorf JL; Reutenauer JE; Hughes CA; Eads N; Willison J; Powers M; Lerman C
Am J Med Genet; 1997 Dec; 73(3):296-303. PubMed ID: 9415688
[TBL] [Abstract][Full Text] [Related]
14. Intention to pursue genetic testing for breast cancer among women due for screening mammography.
Gwyn K; Vernon SW; Conoley PM
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):96-102. PubMed ID: 12582018
[TBL] [Abstract][Full Text] [Related]
15. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
[TBL] [Abstract][Full Text] [Related]
16. The pros and cons of genetic testing for breast and ovarian cancer risk.
Frank TS; Braverman AM
Int J Fertil Womens Med; 1999; 44(3):139-45. PubMed ID: 10435912
[TBL] [Abstract][Full Text] [Related]
17. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
Geller G; Doksum T; Bernhardt BA; Metz SA
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
[TBL] [Abstract][Full Text] [Related]
18. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
19. Decision-making about breast cancer susceptibility testing: how similar are the attitudes of physicians, nurse practitioners, and at-risk women?
Geller G; Bernhardt BA; Doksum T; Helzlsouer KJ; Wilcox P; Holtzman NA
J Clin Oncol; 1998 Aug; 16(8):2868-76. PubMed ID: 9704741
[TBL] [Abstract][Full Text] [Related]
20. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.
Hallowell N; Foster C; Eeles R; Ardern-Jones A; Watson M
Soc Sci Med; 2004 Aug; 59(3):553-65. PubMed ID: 15144764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]